120/80 Health Group Posts Eighth Straight Year of Record Growth
Image
New York – September 29, 2026 -- 120/80 Health Group has logged its eighth consecutive year of record growth, fueled by new client wins and deepening relationships across healthcare and life sciences.
Top-10 biopharma and diagnostic firms sign on for AI-driven work
The firm added multiple category-leading clients in 2026 and began working with several top-10 global biopharmaceutical and diagnostic companies applying AI to drug, test and device development. The agency has shifted from brand-awareness communications for early-stage digital health startups to a strategic consultancy serving businesses from pre-Series A through publicly traded companies.